---
name: à¸›à¸£à¸°à¸à¸²à¸¨à¸à¸£à¸°à¸—à¸£à¸§à¸‡à¸ªà¸²à¸˜à¸²à¸£à¸“à¸ªà¸¸à¸‚ à¹€à¸£à¸·à¹ˆà¸­à¸‡ à¸£à¸°à¸šà¸¸à¸Šà¸·à¹ˆà¸­à¸¢à¸²à¹€à¸ªà¸žà¸•à¸´à¸”à¹ƒà¸«à¹‰à¹‚à¸—à¸©à¹ƒà¸™à¸›à¸£à¸°à¹€à¸ à¸— 4 à¸ž.à¸¨. 2566
date: '2024-01-17'
category: à¸‡ à¸žà¸´à¹€à¸¨à¸©
volume: 141
section: 17
page: 13
source: 'https://ratchakitcha.soc.go.th/documents/17029.pdf'
draft: true
---

# à¸›à¸£à¸°à¸à¸²à¸¨à¸à¸£à¸°à¸—à¸£à¸§à¸‡à¸ªà¸²à¸˜à¸²à¸£à¸“à¸ªà¸¸à¸‚ à¹€à¸£à¸·à¹ˆà¸­à¸‡ à¸£à¸°à¸šà¸¸à¸Šà¸·à¹ˆà¸­à¸¢à¸²à¹€à¸ªà¸žà¸•à¸´à¸”à¹ƒà¸«à¹‰à¹‚à¸—à¸©à¹ƒà¸™à¸›à¸£à¸°à¹€à¸ à¸— 4 à¸ž.à¸¨. 2566

'1>@01>#1/2@$@12B N1APà¸­ 1>&BAPà¸­0@N2à¸ž!> Qà¸«OP#1Q%'1>N.# b à¸ž . 0 . `cdd P 0#?PN'à¹‡%@12/à¸„/1'1?&'1BAPà¸­0@N2à¸ž!> Qà¸«OP#1Q%'1>N.# b !@/'1>//à¸¥à¸«/@00@N2à¸ž!> P 01>&BAPà¸­ Nà¸ž>"à¸­% Oà¸¥>N'à¸¥?P0%O'à¸¥ Nà¸žAPà¸­'1>P0%à¹ŒQ%@1à¸„/&à¸„B/à¹@?& C Oà¸¥0@N2à¸ž!> Qà¸«OP#1 Q%'1>N.# b !@/'1>//à¸¥à¸«/@00@N2à¸ž!> Qà¸«ON'à¹‡%R' O /0à¸„/@/N1?0&1Oà¸­0Oà¸¥>/?'1>2>#$>.@à¸ž à¸­@0?0à¸­à¹@%@!@/à¸„/@/Q%/@!1@ `b /11à¸„2à¸­ Oà¸«Nà¸ž1>1@&??!>Qà¸«OQO'1>//à¸¥à¸«/@00@N2à¸ž!> à¸ž . 0 . `cdb Oà¸¥>/@!1@ `9 /11à¸„2à¸­ Oà¸«N'1>//à¸¥à¸«/@00@N2à¸ž!> 1?à¸/%!1?/N@@11>#1/2@$@12B P 0à¸„/@/Nà¸«O%à¸­&à¸­à¸„>11/@1'à¹‰à¸­?%Oà¸¥>'1@&'1@/0@N2à¸ž!> @à¸­à¸­'1>@0R/O ? !Nà¸­R'%?Q Oà¸­ _ '1>@0%?QN1?0/N@ Ã¬ '1>@01>#1/2@$@12B N1APà¸­ 1>&BAPà¸­0@N2à¸ž!> Qà¸«OP#1 Q%'1>N.# b à¸ž . 0 . `cdd Ã® Oà¸­ ` '1>@0%?QQà¸«OQO&?à¸„?&!?QO!N/?%"? @/?%'1>@0Q%1@>@%BN&1@N'à¹‡%!O%R' Oà¸­ a Qà¸«O0Nà¸¥> ( _ ) '1>@01>#1/2@$@12B N1APà¸­ 1>&BAPà¸­0@N2à¸ž!> Qà¸«OP#1Q%'1>N.# b à¸ž . 0 . `cdc à¸¥/?%#?P b !Bà¸¥@à¸„/ à¸ž . 0 . `cdc ( ` ) '1>@01>#1/2@$@12B N1APà¸­ 1>&BAPà¸­0@N2à¸ž!> Qà¸«OP#1Q%'1>N.# b ( &?&#?P ` ) à¸ž . 0 . `cdd à¸¥/?%#?P _e /?%@à¸„/ à¸ž . 0 . `cdd Oà¸­ b Qà¸«O2@1Nà¸„/?#?PQOQ%@1(à¸¥>!0@N2à¸ž!> Qà¸«OP#1Q%'1>N.# _ à¸«1Aà¸­'1>N.# ` #?P1>&BAPà¸­ Q%&??#O@0'1>@0%?QN'à¹‡%0@N2à¸ž!> Qà¸«OP#1Q%'1>N.# b !@/'1>//à¸¥à¸«/@00@N2à¸ž!> P 0Qà¸«O1//"@ ( _ ) /?!"B#?PN1?0APà¸­N'à¹‡%à¸­0N@à¸­AP%O!N/?Pà¸„121O@#@Nà¸„/?à¸­0N@N ? 0/?%?&0@N2à¸ž!> Qà¸«OP#1 ? à¸¥N@/ ( ` ) à¸­à¸¥#à¹Œ (salts) à¸­0@N2à¸ž!> Qà¸«OP#1 ? à¸¥N@/ #?Q%?Q R/N/N@>/?à¸„/@/NO/O%Q à¸«1Aà¸­%à¹@R'QONà¸žAPà¸­@1Q N/O%O!N>/?@11>&Bà¸„/@/NO/O% à¸«1Aà¸­NAPà¸­%RR/ON'à¹‡%@1Nà¸ž@> à¸«1Aà¸­N'à¹‡%1?#?P%à¹@R'QONà¸žAPà¸­N'à¹‡%2@1à¸„/&à¸„B/à¸„B.@à¸žQ%@1!1//>Nà¸„1@>à¸«à¹Œ Oà¸¥>à¸„/&à¸„B/à¸„B.@à¸žà¸­@1!1/2@1N2à¸ž!> Q%1N@@0@PN'à¹‡%Nà¸„1APà¸­/Aà¸­Oà¸ž#0à¹Œ!@/à¸«/@0/N@ O /0 Nà¸„1APà¸­/Aà¸­Oà¸ž#0à¹Œ Oà¸¥>!Oà¸­QO!@//?!"B'1>2à¸„à¹Œà¸­Nà¸„1APà¸­/Aà¸­Oà¸ž#0à¹Œ%?Q% '1>@0  /?%#?P 26 $?%/@à¸„/ à¸ž . 0 . `c 66 à¸¥%N@% 01?OO/ 1?à¸/%!1?/N@@11>#1/2@$@12B à¸«à¸™à¹‰à¸² 13 à¹€à¸¥ïœŠà¸¡ 141 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 17 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 17 à¸¡à¸à¸£à¸²à¸„à¸¡ 2567

&??#O@"'#>@0#>##/2@$@#2B N#AP/ #>&BAP/"@N2!> Qà¸«OP#1Q%'#>N # b  . 0 . `cdd %O@ ? & #?P AP/"@N2!> Qà¸«OP#1 AP/#@Nà¸„!? NAP/%R _ /@N!>à¸„ O/%R0R # à¹Œ (acetic anhydride) ethanoyl ethanoate ` />?#>%à¸„%/R# à¹Œ (acetyl chloride) ethanoyl chloride a O/%@ - N//#à¹ŒPà¸„#>#?% ( alpha -ergocryptine) (6a R ,9 R )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-5-(2-methylpropyl)- 2-(propan-2-yl)-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#? Q /%B?%$à¹Œ!N@N N/2N#/#à¹Œ O%>/?N#/#à¹Œ Q N /"@N2!> Qà¸«OP#1 ? %N@/ N/O%O!NO/%@ - N//#à¹ŒP à¸„#>#?% ( alpha - ergocryptine) @PN'à¹‡%2N/%(2!Q% !O@#?&#?PR O @Q%#>N&?"% "@!@!à¸«!@"/N@ O /" "@à¸«#A/ @Q%#>N&?"% !O@#?&/?!"B//$#$>N !@!'#>!/%à¸«!@" "@N2!> b O/%@ - N//#à¹ŒPà¸„#>#>%?% ( alpha -ergocryptinine) (6a R ,9 S )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-5-(2-methylpropyl)- 2-(propan-2-yl)-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#? Q /%B?%$à¹Œ!N@N N/2N#/#à¹Œ O%>/?N#/#à¹Œ Q N /"@N2!> Qà¸«OP#1 ? %N@/ N/O%O!N O/%@ - N//#à¹ŒPà¸„#> #>%?% ( alpha - ergocryptinine) @PN'à¹‡%2N/%(2!Q%!O@#?& #?PR O @Q%#>N&?"%"@ !@!  à¸«!@"/N@ O /""@

%O@ ? & #?P AP/"@N2!> Qà¸«OP#1 AP/#@Nà¸„!? NAP/%R à¸«#A/@ Q %#>N&?"%!O@#?& /?!"B//$#$>N !@!'#>!/%à¸«!@" "@N2!> c O/%@ - à¸µ%>%/>?P!/>?!@R! à¹Œ (alpha - phenylacetoacetamide à¸«#A/ APAA) 3-oxo-2-phenylbutanamide #/!#?Q//'!>à¸„?% R/PN!/#à¹Œ (optical isomer) /"@N2!> Qà¸«OP#1 ? %N@/ d O/%@ - à¸µ%>%/>?P!/>?P!R%R##%à¹Œ ( alpha -phenylacetoacetonitrile à¸«#A/ APAAN) 3-oxo-2-phenylbutanenitrile #/!#?Q//'!>à¸„?% R/PN!/#à¹Œ (optical isomer) / "@N2!> Qà¸«OP#1 ? %N@/ e b - />%>%>P% - N/O% - N%N/#>%RN/#> ? % (4-anilino- N - phenethylpiperidine à¸«#A/ ANPP) N -phenyl-1-(2- phenylethyl)piperidin -4-amine f # O/%##@%>%> (anthranilic acid) 2-aminobenzoic acid g b - N/? (4-AP) N -phenylpiperidin-4-amine _^ _ - &O/ - b - N/? (1-boc-4-AP) tert -butyl 4-anilinopiperidine-1- carboxylate __ /?%?P!à¸„%@/?% (elymoclavine) (6a R ,10a R )-7-methyl- 4,6,6a,7,8,10a- hexahydroindolo[4,3- fg ]quinolin- 9-yl methanol #/!#?Q/%B?%$à¹Œ!N@N N/2N#/#à¹Œ O%>/?N#/#à¹Œ Q N /"@N2!> Q à¸«OP#1 ? %N@/

%O@ ? & #?P AP/"@N2!> Qà¸«OP#1 AP/#@Nà¸„!? NAP/%R N/O%O!N/?%?P!à¸„%@/?% (elymoclavine) @PN'à¹‡%2N/%(2!Q% !O@#?&#?PR O @Q%#>N&?"% "@!@!à¸«!@"/N@ O /" "@à¸«#A/@Q%#>N&?"% !O@#?&/?!"B//$#$>N!@! '#>!/%à¸«!@" "@N2!> _` N//#à¹ŒPà¸„/#à¹Œ%?% (ergocornine) (6a R ,9 R )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-2,5- bis (propan-2- yl)-3,6-dioxooctahydro-2 H - oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7-methyl- 4,6,6a,7,8,9-hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#?Q/%B?%$à¹Œ!N@N N/2N#/#à¹Œ O%>/?N#/#à¹Œ Q N /"@N2!> Qà¸«OP#1 ? %N@/ N/O%O!N N//#à¹ŒPà¸„/#à¹Œ%?% (ergocornine) @PN'à¹‡%2N/%(2!Q%!O@#?& #?PR O @Q%#>N&?"%"@ !@!à¸«!@"/N@ O /""@ à¸«#A/@Q%#>N&?"%!O@#?& /?!"B//$#$>N!@! '#>!/%  à¸«!@""@N2!> _a N//#à¹ŒPà¸„/#à¹Œ%>%?% (ergocorninine) (6a R ,9 S )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-2,5- bis (propan-2- yl)-3,6-dioxooctahydro-2 H - oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7-methyl- 4,6,6a,7,8,9-hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#?Q/%B?%$à¹Œ!N@N N/2N#/#à¹Œ O%>/?N#/#à¹Œ Q N /"@N2!> Qà¸«OP#1 ? %N@/N/O%O!N N//#à¹ŒPà¸„/#à¹Œ%>%?% (ergocorninine) @PN'à¹‡%2N/%(2!Q% !O@#?&#?PR O @Q%#>N&?"% "@!@!à¸«!@"/N@ O /" "@à¸«#A/@Q%#>N&?"% !O@#?&/?!"B//$#$>N !@!'#>!/%à¸«!@" "@N2!>

%O@ ? & #?P AP/"@N2!> Qà¸«OP#1 AP/#@Nà¸„!? NAP/%R _b N//#à¹ŒPà¸„#>2#?% (ergocristine) (6a R ,9 R )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-5-phenylmethyl-2- (propan-2-yl)-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#?Q/%B?%$à¹Œ!N@N N/2N#/#à¹Œ O%>/?N#/#à¹Œ Q N /"@N2!> Qà¸«OP#1 ? %N@/ N/O%O!N N//#à¹ŒPà¸„#>2#?% (ergocristine) @PN'à¹‡%2N/%(2!Q%!O@#?& #?PR O @Q%#>N&?"%"@ !@!à¸«!@"/N@ O /""@ à¸«#A/@Q%#>N&?"%!O@#?& /?!"B//$#$>N!@! '#>!/%à¸«!@" "@N2!> _ c N//#à¹ŒPà¸„#>2#>%?% (ergocristinine) (6a R ,9 S )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-5-phenylmethyl-2- (propan-2-yl)-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#? Q /%B?%$à¹Œ!N@N N/2N#/#à¹Œ O%>/?N#/#à¹Œ Q N /"@N2!> Qà¸«OP#1 ? %N@/ N/O%O!N N//#à¹ŒPà¸„#>2#>%?% (ergocristinine) @PN'à¹‡%2N/%(2!Q%!O@#?& #?PR O @Q%#>N&?"%"@ !@!à¸«!@"/N@ O /""@ à¸«#A/@Q%#>N&?"%!O@#?& /?!"B//$#$>N!@! '#>!/%à¸«!@" "@N2!> _d N&!@ - N//#à¹ŒPà¸„#>#?% ( beta -ergocryptine) (6a R ,9 R )- N -((2 R ,5 S ,10a S ,10b S )-5- (butan-2-yl)-10b-hydroxy-2- (propan-2-yl)-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#? Q /%B?%$à¹Œ!N@N N/2N#/#à¹Œ O%>/?N#/#à¹Œ Q N /"@N2!> Qà¸«OP#1 ? %N@/ N/O%O!N N&!@ - N//#à¹ŒPà¸„#>#?% ( beta -ergocryptine) @PN'à¹‡%2N/%(2!Q% !O@#?&#?PR O @Q%#>N&?"% "@!@!  à¸«!@"/N@ O /"

%O@ ? & #?P AP/"@N2!> Qà¸«OP#1 AP/#@Nà¸„!? NAP/%R "@à¸«#A/@ Q %#>N&?"% !O@#?&/?!"B//$#$>N !@!'#>!/%à¸«!@" "@N2!> _ e N&!@ - N//#à¹ŒPà¸„#>#>%?% ( beta -ergocryptinine) (6a R ,9 S )- N -((2 R ,5 S ,10a S ,10b S )-5- (butan-2-yl)-10b-hydroxy-2- (propan-2-yl)-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#? Q /%B?%$à¹Œ!N@N N/2N#/#à¹Œ O%>/?N#/#à¹Œ Q N /"@N2!> Qà¸«OP#1 ? %N@/ N/O%O!N N&!@ - N//#à¹ŒPà¸„#>#>%?% ( beta -ergocryptinine) @PN'à¹‡%2N/%(2!Q% !O@#?&#?PR O @Q%#>N&?"% "@!@!à¸«!@"/N@ O /" "@à¸«#A/@Q%#>N&?"% !O@#?&/?!"B//$#$>N !@!'#>!/%à¸«!@" "@N2!> _f N//#à¹ŒPN!##?% (ergometrine) (6a R ,9 R )- N -(( S )-1-hydroxypropan- 2-yl)-7-methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#?Q/%B?%$à¹Œ!N@N N/2N#/#à¹Œ O%>/?N#/#à¹Œ Q N /"@N2!> Qà¸«OP#1 ? %N@/ N/O%O!N N//#à¹ŒPN!##?% (ergometrine) @PN'à¹‡% 2N/%(2!Q%!O@#?& #?PR O @Q%#>N&?"%"@ !@!à¸«!@"/N@ O /""@ à¸«#A/@Q%#>N&?"%!O@#?& /?!"B//$#$>N!@! '#>!/%à¸«!@" "@N2!> _g N//#à¹ŒPN!##>%?% (ergometrinine) (6a R ,9 S )- N -(( S )-1-hydroxypropan- 2-yl)-7-methyl-4,6,6a,7,8,9- #/!#?Q/%B?%$à¹Œ!N@N N/2N#/#à¹Œ O%>/?N#/#à¹Œ Q N /"@N2!>

%O@ ? & #?P AP/"@N2!> Qà¸«OP#1 AP/#@Nà¸„!? NAP/%R hexahydroindolo[4,3- fg ]quinoline-9-carboxamide Qà¸«OP#1 ? %N@/ N/O%O!N N//#à¹ŒPN!##>%?% (ergometrinine) @PN'à¹‡%2N/%(2!Q% !O@#?& #?PR O @Q%#>N&?"% "@!@!à¸«!@"/N@ O /" "@à¸«#A/@Q%#>N&?"% !O@#?&/?!"B//$#$>N !@!'#>!/%à¸«!@" "@N2!> `^ N//#à¹ŒP?% (ergosine) (6a R ,9 R )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-2-methyl-5-(2- methylpropyl)-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#?Q/%B?%$à¹Œ!N@N N/2N#/#à¹Œ O%>/?N#/#à¹ŒQ N /"@N2!> Qà¸«OP#1 ? %N@/ N/O%O!NN//#à¹ŒP ?% (ergosine) @PN'à¹‡% 2N/%(2!Q%!O@#?&#?PR O @Q%#>N&?"%"@!@! à¸«!@"/N@ O /""@à¸«#A/ @Q%#>N&?"%!O@#?&/?!"B //$#$>N!@!'#>!/% à¸«!@""@N2!> `_ N//#à¹ŒP>%?% (ergosinine) (6a R ,9 S )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-2-methyl-5-(2- methylpropyl)-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#? Q /%B?%$à¹Œ!N@N N/2N#/#à¹Œ O%>/?N#/#à¹Œ Q N /"@N2!> Qà¸«OP#1 ? %N@/ N/O%O!N N//#à¹ŒP>%?% (ergosinine) @PN'à¹‡%2N/%(2!Q% !O@#?&#?PR O @Q%#>N&?"% "@!@!à¸«!@"/N@ O /" "@à¸«#A/@Q%#>N&?"% !O@#?&/?!"B//$#$>N !@!'#>!/%à¸«!@" "@N2!>

%O@ ? & #?P AP/"@N2!> Qà¸«OP#1 AP/#@Nà¸„!? NAP/%R `` N//#à¹ŒP!@!?% (ergotamine) (6a R ,9 R )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-2-methyl-5- phenylmethyl-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ] pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#? Q /%B?%$à¹Œ!N@N N/2N#/#à¹Œ O%>/?N#/#à¹Œ Q N /"@N2!> Qà¸«OP#1 ? %N@/ N/O%O!NN//#à¹ŒP!@!?% (ergotamine) @PN'à¹‡%2N/%(2!Q% !O@#?&#?PR O @Q%#>N&?"% "@!@!à¸«!@"/N@ O /" "@à¸«#A/@Q%#>N&?"% !O@#?&/?!"B//$#$>N !@!'#>!/%à¸«!@" "@N2!> `a N//#à¹ŒP!@!>%?% (ergotaminine) (6a R ,9 S )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-2-methyl-5- phenylmethyl-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#? Q /%B?%$à¹Œ!N@N N/2N#/#à¹Œ O%>/?N#/#à¹Œ Q N /"@N2!> Qà¸«OP#1 ? %N@/ N/O%O!N N//#à¹ŒP!@!>%?% (ergotaminine) @PN'à¹‡%2N/%(2!Q% !O@#?&#?PR O @Q%#>N&?"% "@!@!à¸«!@"/N@ O /" "@à¸«#A/@Q%#>N&?"% !O@#?&/?!"B//$#$>N !@!'#>!/%à¸«!@" "@N2!> `b N/#>%> ? %R />?N!! (ethylidene diacetate) 1,1-ethanediol diacetate `c R/P@#/% (isosafrole) 5-(prop-1-enyl)- [1,3]benzodioxole `d R%N/#à¹Œ@R! à¹Œ (lysergamide) (6a R ,9 R )-7-methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#?Q/%B?%$à¹Œ!N@N N/2N#/#à¹Œ O%>/?N#/#à¹Œ

%O@ ? & #?P AP/"@N2!> Qà¸«OP#1 AP/#@Nà¸„!? NAP/%R Q N /"@N2!> Qà¸«OP#1 ? %N@/ N/O%O!N R%N/#à¹Œ@R! à¹Œ (lysergamide) @PN'à¹‡%2N/%(2!Q% !O@#?&#?PR O @Q% #>N&?"%"@!@! à¸«!@"/N@ O /""@ à¸«#A/ @Q%#>N&?"%!O@#?& /?!"B//$#$>N!@! '#>!/%à¸«!@" "@N2!> `e # R%N/#à¹Œ> (lysergic acid) (6a R ,9 R )-7-methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxylic acid `f a , b - N/O! ? ? - ` - ? N!#>% R%>N ! (3,4-MDP-2-P methyl glycidate à¸«#A/ PMK glycidate) methyl 3-(1,3-benzodioxol-5-yl)- 2-methyl-2-oxiranecarboxylate #/!#?Q2N!/#>P/ - R/PN!/#à¹Œ (stereoisomers) /"@N2!> Qà¸«OP#1 ? %N@/ `g # a , b - N/O! ? ? - ` - ? N!#>%R%> >  (3,4-MDP-2-P methyl glycidic acid à¸«#A/ PMK glycidic acid) 3-(1,3-benzodioxol-5-yl)-2- methyl-2-oxiranecarboxylic acid #/!#?Q2N!/#>P/ - R/PN!/#à¹Œ (stereoisomers) /"@N2!> Qà¸«OP#1 ? %N@/ a^ N!#>% O/%@ - à¸µ%>%/>?P!/>?N!! (methyl alpha - phenylacetoacetate à¸«#A/ MAPA) methyl 3-oxo-2- phenylbutanoate #/!#?Q//'!>à¸„?% R/PN!/#à¹Œ (optical isomer) / "@N2!> Qà¸«OP#1 ? %N@/

%O@ ? & #?P AP/"@N2!> Qà¸«OP#1 AP/#@Nà¸„!? NAP/%R a_ a , b - N!#>%?%R //?N%>% - ` - P#@P%% (3,4-methylenedioxyphenyl-2- propanone) 1-([1,3]benzodioxol-5-yl)propan- 2-one a` # N/O% - />?#>%O/%##@%>%> ( N -acetylanthranilic acid) N -acetyl-2-aminobenzoic acid aa %/#à¹ŒN%#@%>% (norfentanyl) N -phenyl- N -piperidin-4- ylpropanamide ab N/O% - N%N/#>% - b - RN/#>P % ( N -phenethyl-4-piperidone à¸«#A/ NPP) 1-(2-phenylethyl)piperidin-4-one ac _ - N%>% - ` - P#@P%% (1-phenyl-2-propanone) 1-phenylpropan-2-one ad # N%>%/>?!> (phenylacetic acid) 2-phenylacetic acid N/O%O!N# N%>%/>?!>  N'à¹‡%2N/%(2!Q% /?!"BO!N%>P%#2 Q%à¸„/@!NO!O%R!NN>% #O/"%> c !@! à¸«!@"/N@ O /"/@à¸«@# à¸«#A/!@!à¸«!@" /N@ O /"@#à¸„/&à¸„B! à¸„B @/@à¸«@#2?!/à¹Œ #/!"@# N%>%/>?!> #?P(2!/"CNQ%(%>! ? à¸‘à¹Œ /@à¸«@#O%>(%>! ? à¸‘à¹Œ /@à¸«@#2?!/à¹Œ#?PQO/?!"B O!N%>P%#2 ? %N@/ O%>!O/QO!@! /?!"B'#>2à¸„à¹ŒNAP/O!N %>P%#2/@à¸«@#N#N@%?Q%

%O@ ? & #?P AP/"@N2!> Qà¸«OP#1 AP/#@Nà¸„!? NAP/%R ae RN/P#%/% (piperonal) [1,3]benzodioxole-5- carbaldehyde af @#/% (safrole) 5-(prop-2-enyl)- [1,3]benzodioxole "N/O%@#(%>! O@à¸«%N@" %O@NO@ 2N//à¸«#A/!?R/OQ% à¸„#/&à¸„#/A#/!"@ 2N/%!N@N/A#?P!? @#/% O%>%QO@!?% @A#?P!?@#/% P "!O/!?%@à¸«#A/ O/à¸„/@!#>&B/N@N'à¹‡% %QO@!?%@A O%>!? /?!"B'#>2à¸„à¹ŒNAP/QO '#>P"%à¹Œ Q%>@# !@!à¸«!@"/N@ O /" "@ à¸«!@"/N@ O /" (%>! ? à¸‘à¹Œ2!B%R# à¸«!@"/N@ O /"/@à¸«@# à¸«!@"/N@ O /" Nà¸„#AP/2O@/@ à¸«#A/ à¸«!@"/N@ O /" /?!"B/?%!#@" #?Q%?Q R!N#/!"@@#%O@(N@% %QO@!?%@A#?P!? @#/% @P!O/ O @N%>%@#!@! !@!#@ d^ Oà¸«N '#>!/%à¸«!@" "@N2!> Powered by TCPDF (www.tcpdf.org)
